Human Papillomavirus and Coronary Artery Disease in Climacteric Women: Is There an Association?

Luciane Maria Oliveira Brito1, Haissa Oliveira Brito1, Rita da Graça Carvalhal Frazão Corrêa1

  • 1Tumor and DNA Biobank of Maranhão, Federal University of Maranhão, São Luís, Brazil.

Insights

Human papillomavirus (HPV) infection is linked to coronary artery disease (CAD) in climacteric women. Women with HPV showed a significantly higher likelihood of developing CAD, especially with high-risk HPV types.

Area of Science:

  • Cardiology
  • Virology
  • Epidemiology

Background:

  • Cardiovascular diseases (CVDs) are a major global health concern.
  • Emerging evidence suggests viral infections, including human papillomavirus (HPV), may contribute to atherosclerosis.
  • Data on the association between HPV infection and coronary artery disease (CAD) in women remains limited.

Purpose of the Study:

  • To explore the potential association between HPV infection and the presence of CAD in climacteric women.
  • To determine if HPV status is an independent risk factor for CAD in this demographic.

Main Methods:

  • A study involving 52 climacteric women investigated the presence of CAD and cervical HPV DNA.
  • Data on social, demographic, metabolic profiles, and cardiovascular risk factors were collected and analyzed.
  • Statistical analysis, including adjustment for confounding variables, was performed to assess the association.

Main Results:

  • A significant association was found between cervical HPV infection and CAD in climacteric women.
  • HPV-positive women demonstrated a 3.74 times higher odds of having CAD compared to HPV-negative women.
  • Infection with high-risk HPV types further increased the likelihood of CAD (OR = 4.90).

Conclusions:

  • The findings suggest a potential link between HPV infection and CAD in climacteric women.
  • HPV infection may represent an independent risk factor for CAD in this population.
  • Further research is warranted to elucidate the underlying biological mechanisms connecting HPV and cardiovascular health.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
909
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
387
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
220
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
340
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
601
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
327